Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study
Aim. Evaluation of the practice of using trimebutine (tablets, 300 mg, extended release), for the treatment of patients with functional gastrointestinal disorders (FGID) in primary health care. Materials and methods. A prospective observational multicenter non-interventional study was carried out...
Guardado en:
Autores principales: | Dmitry N. Andreev, Igor V. Maev |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
"Consilium Medicum" Publishing house
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31a3bd3ed87e4946bfb86be231e66c41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cólico biliar inducido por morfina
por: Berger,Zoltán, et al.
Publicado: (2017) -
Resultados de la colecistectomía a 10 años plazo
por: Csendes J,Attila, et al.
Publicado: (2000) -
Healthcare System-to-System Cost Variability in the Care of Pediatric Abdominal Pain-Associated Functional Gastrointestinal Disorders
por: Michelle Livitz, et al.
Publicado: (2021) -
Frequency of Different Psychiatric Disorders in Patients With Functional Bowel Disorders: A Short Report
por: Bahareh Fakhraei, et al.
Publicado: (2015) -
Development of colonic transit time and ultrasound imaging tools as objective indicators for assessing abnormal defecation associated with food intake: a narrative review based on previous scientific knowledge
por: Yohei Okawa
Publicado: (2021)